Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Eleopra

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Neurotoxicity Research|June 21, 2006
Clinical use of non-A botulinum toxins: botulinum toxin type BD Dressler, R Eleopra
Journal of Neurosurgical Sciences|November 25, 2003
[Treatment of spasticity with botulinum toxin]R Eleopra, R Quatrale, V Tugnoli
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|April 23, 1999
Hyperhidrosis and sympathetic skin response in chronic alcoholic patientsV Tugnoli, R Eleopra, D De Grandis
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1997
The variability in the clinical effect induced by botulinum toxin type A: the role of muscle activity in humansR Eleopra, V Tugnoli, D De Grandis
Italian Journal of Neurological Sciences|December 1, 1991
Unusual case of Fahr syndrome with motoneuron diseaseR Eleopra, I Accurti, W Neri, et al.
Neurology|April 1, 1996
Botulinum toxin treatment in the facial muscles of humans: evidence of an action in untreated near muscles by peripheral local diffusionR Eleopra, V Tugnoli, L Caniatti, et al.
Expert Opinion on Investigational Drugs|July 2, 2005
The therapeutic use of botulinum toxinV Tugnoli, R Eleopra, C Montecucco, et al.
Neuroscience Letters|March 14, 1997
Botulinum neurotoxin serotype C: a novel effective botulinum toxin therapy in humanR Eleopra, V Tugnoli, O Rossetto, et al.
Neuroscience Letters|December 17, 1998
Different time courses of recovery after poisoning with botulinum neurotoxin serotypes A and E in humansR Eleopra, V Tugnoli, O Rossetto, et al.
Neurotoxicity Research|June 21, 2006
Clinical use of non-A botulinum toxins: botulinum toxin type C and botulinum toxin type FR Eleopra, V Tugnoli, R Quatrale, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Neurotoxicity Research|June 21, 2006
Clinical use of non-A botulinum toxins: botulinum toxin type BD Dressler, R Eleopra
Journal of Neurosurgical Sciences|November 25, 2003
[Treatment of spasticity with botulinum toxin]R Eleopra, R Quatrale, V Tugnoli
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|April 23, 1999
Hyperhidrosis and sympathetic skin response in chronic alcoholic patientsV Tugnoli, R Eleopra, D De Grandis
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1997
The variability in the clinical effect induced by botulinum toxin type A: the role of muscle activity in humansR Eleopra, V Tugnoli, D De Grandis
Italian Journal of Neurological Sciences|December 1, 1991
Unusual case of Fahr syndrome with motoneuron diseaseR Eleopra, I Accurti, W Neri, et al.
Neurology|April 1, 1996
Botulinum toxin treatment in the facial muscles of humans: evidence of an action in untreated near muscles by peripheral local diffusionR Eleopra, V Tugnoli, L Caniatti, et al.
Expert Opinion on Investigational Drugs|July 2, 2005
The therapeutic use of botulinum toxinV Tugnoli, R Eleopra, C Montecucco, et al.
Neuroscience Letters|March 14, 1997
Botulinum neurotoxin serotype C: a novel effective botulinum toxin therapy in humanR Eleopra, V Tugnoli, O Rossetto, et al.
Neuroscience Letters|December 17, 1998
Different time courses of recovery after poisoning with botulinum neurotoxin serotypes A and E in humansR Eleopra, V Tugnoli, O Rossetto, et al.
Neurotoxicity Research|June 21, 2006
Clinical use of non-A botulinum toxins: botulinum toxin type C and botulinum toxin type FR Eleopra, V Tugnoli, R Quatrale, et al.
Pageof 5